1
|
Dente M, Riccardo F, Declich S, Milano A, Robbiati C, Agrimi U, Mantovani A, Morabito S, Scavia G, Cubadda F, Villa L, Monaco M, Mancini L, Carere M, Marcheggiani S, Lavazza A, Farina M, Dar O, Villa M, Coggi PT, Brusaferro S. Strengthening preparedness against global health threats: A paradigm shift based on One Health approaches. One Health 2022; 14:100396. [PMID: 35686149 PMCID: PMC9171516 DOI: 10.1016/j.onehlt.2022.100396] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2022] [Revised: 05/02/2022] [Accepted: 05/04/2022] [Indexed: 11/25/2022] Open
Abstract
The implementation of preparedness strategies to prevent and mitigate the impact of global health threats poses several challenges. It should promptly identify cross-cutting drivers of pandemic threats, assess context-specific risks, engage multiple stakeholders, and translate complex data from multiple sources into accessible information for action. This requires a coordinated, multidisciplinary and multisectoral effort engaging systems that, most of the time, work in isolation. The One Health (OH) approach promotes the collaboration and communication among different disciplines and sectors, and could be applied across the preparedness phases at national and international level. We discuss here gaps and needs in preparedness strategies, which can benefit from the OH approach, and a set of actionable recommendations, as shared with the G20–2021 with a dedicated Policy Brief. The discussion adds to the current debate about OH operationalization and promotes a paradigm shift towards coordinated prevention and preparedness strategies for early assessment and management of global health threats.
Collapse
|
2
|
Kana S, Monaco M, Kohler S, Eversole R, Essani K. A FliC armed oncolytic tanapoxvirus causes regression of colorectal cancer xenografts in immuno-competent models. Eur J Cancer 2020. [DOI: 10.1016/s0959-8049(20)31233-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
3
|
Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, Ryschkewitsch C, Major EO, Ohayon J, Schindler MK, Beck E, Reoma LB, Jacobson S, Reich DS, Nath A. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy. N Engl J Med 2019; 380:1597-1605. [PMID: 30969503 DOI: 10.1056/nejmoa1815039] [Citation(s) in RCA: 219] [Impact Index Per Article: 43.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND Progressive multifocal leukoencephalopathy (PML) is an opportunistic brain infection that is caused by the JC virus and is typically fatal unless immune function can be restored. Programmed cell death protein 1 (PD-1) is a negative regulator of the immune response that may contribute to impaired viral clearance. Whether PD-1 blockade with pembrolizumab could reinvigorate anti-JC virus immune activity in patients with PML was unknown. METHODS We administered pembrolizumab at a dose of 2 mg per kilogram of body weight every 4 to 6 weeks to eight adults with PML, each with a different underlying predisposing condition. Each patient received at least one dose but no more than three doses. RESULTS Pembrolizumab induced down-regulation of PD-1 expression on lymphocytes in peripheral blood and in cerebrospinal fluid (CSF) in all eight patients. Five patients had clinical improvement or stabilization of PML accompanied by a reduction in the JC viral load in the CSF and an increase in in vitro CD4+ and CD8+ anti-JC virus activity. In the other three patients, no meaningful change was observed in the viral load or in the magnitude of antiviral cellular immune response, and there was no clinical improvement. CONCLUSIONS Our findings are consistent with the hypothesis that in some patients with PML, pembrolizumab reduces JC viral load and increases CD4+ and CD8+ activity against the JC virus; clinical improvement or stabilization occurred in five of the eight patients who received pembrolizumab. Further study of immune checkpoint inhibitors in the treatment of PML is warranted. (Funded by the National Institutes of Health.).
Collapse
Affiliation(s)
- Irene Cortese
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Pawel Muranski
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Yoshimi Enose-Akahata
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Seung-Kwon Ha
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Bryan Smith
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - MariaChiara Monaco
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Caroline Ryschkewitsch
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Eugene O Major
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Joan Ohayon
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Matthew K Schindler
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Erin Beck
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Lauren B Reoma
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Steve Jacobson
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Daniel S Reich
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| | - Avindra Nath
- From the Neuroimmunology Clinic (I.C., J.O.), the Viral Immunology Section (Y.E.-A., S.J.), the Section of Infections of the Nervous System (B.S., L.B.R., A.N.), the Laboratory of Molecular Medicine and Neuroscience (M.M., C.R., E.O.M.), and the Translational Neuroradiology Section (S.-K.H., M.K.S., E.B., D.S.R.), National Institute of Neurological Disorders and Stroke, and the Hematology Branch, National Heart, Lung, and Blood Institute (P.M.), National Institutes of Health, Bethesda, MD; and the Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York (P.M.)
| |
Collapse
|
4
|
Blackwell KL, Paluch-Shimon S, Campone M, Conte P, Petrakova K, Favret A, Blau S, Beck JT, Miller M, Sutradhar S, Monaco M, Burris HA. Abstract P5-21-18: Subsequent treatment for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received ribociclib + letrozole vs placebo + letrozole in the phase III MONALEESA-2 study. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-21-18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: In the Phase III MONALEESA-2 study (NCT01958021), ribociclib (RIB; cyclin-dependent kinase 4/6 inhibitor [CDK4/6i]) + letrozole (LET) significantly prolonged progression-free survival (PFS) vs placebo (PBO) + LET in postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC). The optimal treatment sequence following first-line CDK4/6i-based therapy is not yet known. Here we report the subsequent therapies received following discontinuation from MONALEESA-2.
Methods: The MONALEESA-2 study enrolled 668 patients (pts) with HR+, HER2– ABC. Pts were randomized 1:1 to receive RIB (600 mg/day; 3-weeks-on/1-week-off) + LET (2.5 mg/day; continuous) or PBO + LET. Following discontinuation of MONALEESA-2 study treatment, pts were followed for information regarding post-study treatment, including type and duration of therapy.
Results: At data cut-off (January 2, 2017), the median duration of follow-up was 26.4 months. Median PFS was 25.3 vs 16.0 months in the RIB + LET vs PBO + LET arms (hazard ratio=0.568; 95% confidence interval [CI]: 0.457–0.704; p=9.63x10–8). 203 (60.8%) vs 246 (73.7%) pts had discontinued RIB + LET vs PBO + LET. The median time to end of treatment was 20.3 months in the RIB + LET arm vs 13.7 months in the PBO + LET arm. First subsequent antineoplastic treatment was reported for 172/203 (84.7%) vs 212/246 (86.2%) pts who received RIB + LET vs PBO + LET; second subsequent therapy was reported for 45/203 (22.2%) vs 68/246 (27.6%) pts. The median time to first subsequent therapy (from randomization to the first post-study dose of therapy) was 24.2 (95% CI: 20.9–27.6) vs 16.7 (95% CI: 14.8–19.3) months in pts who received RIB + LET vs PBO + LET; median time to initiation of second subsequent therapy was not reached in either arm. The most common type of first subsequent therapy was single-agent hormonal therapy in 90 (44.3%) vs 87 (35.4%) pts who discontinued RIB + LET vs PBO + LET; chemotherapy was the most common second subsequent therapy in 20 (9.9%) vs 36 (14.6%) pts. Chemotherapy alone was the first subsequent treatment after MONALEESA-2 discontinuation in 32 (15.8%) vs 55 (22.4%) pts treated with RIB + LET vs PBO + LET.
Conclusions: RIB + LET significantly prolongs PFS and delays the start of subsequent lines of therapy vs PBO + LET in pts with HR+, HER2– ABC. The most common first subsequent therapy following discontinuation of RIB + LET or PBO + LET was single-agent hormonal therapy, and fewer pts treated with RIB + LET received subsequent chemotherapy compared with those who received PBO + LET.
Citation Format: Blackwell KL, Paluch-Shimon S, Campone M, Conte P, Petrakova K, Favret A, Blau S, Beck JT, Miller M, Sutradhar S, Monaco M, Burris HA. Subsequent treatment for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer who received ribociclib + letrozole vs placebo + letrozole in the phase III MONALEESA-2 study [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-21-18.
Collapse
Affiliation(s)
- KL Blackwell
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - S Paluch-Shimon
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - M Campone
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - P Conte
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - K Petrakova
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - A Favret
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - S Blau
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - JT Beck
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - M Miller
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - S Sutradhar
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - M Monaco
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| | - HA Burris
- Duke University Medical Center, Durham, NC; Sheba Medical Center, Ramat Gan, Israel; Institut de Cancérologie de l'Ouest – René Gauducheau Centre de Recherche en Cancérologie, Nantes, France; University of Padova and Istituto Oncologico Veneto, IRCCS, Padova, Italy; Masaryk Memorial Cancer Institute, Brno, Czech Republic; Virginia Cancer Specialists, Arlington, VA; Rainier Hematology–Oncology, Northwest Medical Specialties, Puyallup, WA; Highlands Oncology Group, Fayetteville, AR; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Sarah Cannon Research Institute, Nashville, TN
| |
Collapse
|
5
|
Fedele M, Paciello O, De Biase D, Monaco M, Vitiello M, Rea D, Luciano A, Arra C, Fusco A. Hmga2 Cooperates with Either p27 Deficiency or Cdk4 R24C Mutation in Pituitary Tumourigenesis. J Comp Pathol 2018. [DOI: 10.1016/j.jcpa.2017.10.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Forsythe A, Chandiwana D, Dolph M, Tremblay G, Monaco M. Matching-adjusted indirect treatment comparison of ribociclib and palbociclib as first-line treatments for HR+, HER2– ABC. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Giufrè M, Ricchizzi E, Accogli M, Barbanti F, Monaco M, Pimentel de Araujo F, Farina C, Fazii P, Mattei R, Sarti M, Barozzi A, Buttazzi R, Cosentino M, Nardone M, Savini V, Spigaglia P, Pantosti A, Moro ML, Cerquetti M. Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study. Clin Microbiol Infect 2017; 23:961-967. [PMID: 28412380 DOI: 10.1016/j.cmi.2017.04.006] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 03/30/2017] [Accepted: 04/06/2017] [Indexed: 11/24/2022]
Abstract
OBJECTIVES To determine prevalence and risk factors for colonization by multidrug-resistant organisms (MDROs) in long-term care facility (LTCF) residents in Italy. Genotypes of MDRO isolates were investigated. METHODS A point-prevalence study was conducted at 12 LTCFs located in four Italian cities (2 February to 14 March 2015). Rectal swabs, faeces and nasal/auxiliary swabs were cultured for extended-spectrum β-lactamase (ESBL)- and/or carbapenemase-producing Enterobacteriaceae, Clostridium difficile and methicillin-resistant Staphylococcus aureus (MRSA) respectively. Antimicrobial susceptibility testing, detection of ESBL and/or carbapenemase genes and molecular typing of MDROs were performed. Risk factors for colonization were determined by univariate and multivariate analysis. RESULTS A total of 489 LTCF residents aged ≥65 years were enrolled. The prevalence of colonization by ESBL-producing Enterobacteriaceae, MRSA and C. difficile was 57.3% (279/487), 17.2% (84/487) and 5.1% (21/409) respectively. Carriage rate of carbapenemase-producing Enterobacteriaceae was 1% (5/487). Being bedridden was a common independent risk factor for colonization by all MDROs, although risk factors specific for each MDRO were identified. ESBL-producing Escherichia coli carriage was associated with the sequence type (ST) 131-H30 subclone, but other minor STs predominated in individual LTCF or in LTCFs located in the same city, suggesting a role for intrafacility or local transmission. Similarly, MRSA from LTCF residents belonged to the same spa types/ST clones (t008/ST8 and t032/ST22) commonly found in Italian acute-care hospitals, but infrequent spa types were recovered in individual LTCFs. The prevalent C. difficile PCR ribotypes were 356/607 and 018, both common in Italian acute-care hospitals. CONCLUSIONS MDRO colonization is common among residents in Italian LTCFs.
Collapse
Affiliation(s)
- M Giufrè
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - E Ricchizzi
- Health and Social Agency, Emilia-Romagna Region, Bologna, Italy
| | - M Accogli
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - F Barbanti
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - M Monaco
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | | | - C Farina
- Papa Giovanni XXIII Hospital, Bergamo, Italy
| | - P Fazii
- Spirito Santo Hospital, Pescara, Italy
| | - R Mattei
- Campo di Marte Hospital, Lucca, Italy
| | - M Sarti
- S. Agostino-Estense-Baggiovara Hospital, Modena, Italy
| | - A Barozzi
- S. Agostino-Estense-Baggiovara Hospital, Modena, Italy
| | - R Buttazzi
- Health and Social Agency, Emilia-Romagna Region, Bologna, Italy
| | - M Cosentino
- Papa Giovanni XXIII Hospital, Bergamo, Italy
| | - M Nardone
- Campo di Marte Hospital, Lucca, Italy
| | - V Savini
- Spirito Santo Hospital, Pescara, Italy
| | - P Spigaglia
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - A Pantosti
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - M L Moro
- Health and Social Agency, Emilia-Romagna Region, Bologna, Italy
| | - M Cerquetti
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
| |
Collapse
|
8
|
Sanchini A, Del Grosso M, Villa L, Ammendolia M, Superti F, Monaco M, Pantosti A. Typing of Panton-Valentine leukocidin-encoding phages carried by methicillin-susceptible and methicillin-resistant Staphylococcus aureus from Italy. Clin Microbiol Infect 2014; 20:O840-6. [DOI: 10.1111/1469-0691.12679] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2013] [Revised: 03/24/2014] [Accepted: 05/12/2014] [Indexed: 01/07/2023]
|
9
|
Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network EuSCAPE-Italy C, Grundmann H, Pantosti A, Rossolini GM. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014; 19. [DOI: 10.2807/1560-7917.es2014.19.42.20939] [Citation(s) in RCA: 157] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Consecutive non-replicate clinical isolates (n=191) of carbapenem non-susceptible Enterobacteriaceae were collected from 21 hospital laboratories across Italy from November 2013 to April 2014 as part of the European Survey on Carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) represented 178 (93%) isolates with 76 (43%) respectively resistant to colistin, a key drug for treating carbapenamase-producing Enterobacteriaceae. KPC-KP colistin-resistant isolates were detected in all participating laboratories. This underscores a concerning evolution of colistin resistance in a setting of high KPC-KP endemicity.
Collapse
Affiliation(s)
- M. Monaco
- Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
- MM and TG have equally contributed to this work
| | - T Giani
- MM and TG have equally contributed to this work
- Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - M Raffone
- Federico II University Hospital, Neaples, Italy
- Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - F Arena
- Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - A Garcia-Fernandez
- Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - S Pollini
- Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | | | - H Grundmann
- Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands
| | - A Pantosti
- Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - G M Rossolini
- Clinical Microbiology and Virology Unit, Florence Careggi University Hospital, Florence, Italy
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
- Department of Medical Biotechnologies, University of Siena, Siena, Italy
| |
Collapse
|
10
|
Accogli M, Giani T, Monaco M, Giufre M, Garcia-Fernandez A, Conte V, D'Ancona F, Pantosti A, Rossolini GM, Cerquetti M. Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. J Antimicrob Chemother 2014; 69:2293-6. [DOI: 10.1093/jac/dku132] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Pepino P, Coronella G, Oliviero P, Contaldo A, Provenzano R, Giordano S, Pota V, Luciano A, Monaco M, Schiavone V. Re-operation beating heart valve surgery post myocardial revascularization with patent grafts. J Cardiothorac Surg 2013. [PMCID: PMC3845731 DOI: 10.1186/1749-8090-8-s1-o5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
12
|
Coronella G, Pepino P, Pezzella E, Contaldo A, Provenzano R, Oliviero P, Di Maio S, Schiavone V, Giordano S, Monaco M. Off pump reduction aortoplasty in ascending aortic aneurysm. J Cardiothorac Surg 2013. [PMCID: PMC3844513 DOI: 10.1186/1749-8090-8-s1-o14] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
13
|
Nicoletti G, Schito G, Fadda G, Boros S, Nicolosi D, Marchese A, Spanu T, Pantosti A, Monaco M, Rezza G, Cassone A, Garaci E. Bacterial Isolates from Severe Infections and Their Antibiotic Susceptibility Patterns in Italy: a Nationwide Study in the Hospital Setting. J Chemother 2013; 18:589-602. [PMID: 17267336 DOI: 10.1179/joc.2006.18.6.589] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The most frequent agents of severe bacterial infections and their antibiotic susceptibility patterns were determined in patients admitted to 45 Italian hospitals over the years 2002-2003. The most common diagnoses were: sepsis (33.8%), pneumonia (9.4%), intravascular catheter-associated infections (9.3%) and ventilator-associated pneumonia (8.1%). Overall, 5115 bacterial isolates were identified from 4228 patients. Three bacterial species, Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli, accounted for more than 50% of the isolates. Other prevalent bacterial isolates were Staphylococcus epidermidis and Enterococcus faecalis, while Acinetobacter baumanii ranked third among all Intensive Care Unit (ICU) isolates. 7% of S. aureus had intermediate resistance to vancomycin. Although E. faecalis displayed no vancomycin resistance, 34% of vancomycin-resistant isolates were found among Enterococcus faecium, one of the highest rates found to date, emphasizing the difference between these two enterococcal species. All the Gram-positive pathogens were susceptible to linezolid, with the exception of approximately 2% of the enterococcal isolates that were intermediate with a minimum inhibitory concentration (MIC)=4 microg/ml. Almost 10% of Escherichia coli, 14% of Klebsiella pneumoniae, 22% of Serratia marcescens and 50% of Enterobacter cloacae were non-susceptible to cefotaxime. Amikacin was the most active antibiotic against P. aeruginosa that showed lack of susceptibility to ceftazidime, gentamicin, piperacillin and ciprofloxacin ranging from 20 to 35%. Finally, Acinetobacter baumanii showed a high level of resistance to all the antibiotics tested including imipenem (58%). The results obtained in this study, the first of its kind in Italy, offer indications for guiding empirical therapy and implementing specific interventions to fight antibiotic-resistant bacterial infections and their transmission in the hospital setting in Italy.
Collapse
Affiliation(s)
- G Nicoletti
- Institute of Microbiology, University of Catania, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Giannella M, Monaco M, Nicosia R, Chiarini F, Pantosti A, Venditti M. A Dialysis Patient with Bacteremia Caused by a Community-Acquired Methicillin-ResistantStaphylococcus aureus(CA-MRSA) Carrying the Staphylococcal Chromosome Cassette (SCC) mec type V. J Chemother 2013; 20:402-4. [DOI: 10.1179/joc.2008.20.3.402] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
15
|
Bedenić B, Schmidt H, Herold S, Monaco M, Plecko V, Kalenić S, Katíc S, Skrlin-Subić J. Epidemic and Endemic Spread ofKlebsiella pneumoniaeProducing SHV-5 Beta-Lactamase in Dubrava University Hospital, Zagreb, Croatia. J Chemother 2013; 17:367-75. [PMID: 16167514 DOI: 10.1179/joc.2005.17.4.367] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
Plasmid-encoded resistance to broad-spectrum cephalosporins and aztreonam is becoming a widespread phenomenon in clinical medicine. These antibiotics are inactivated by an array of different extended-spectrum beta-lactamases (ESBLs) which have evolved by point mutations of parental TEM or SHV beta-lactamases. In a previous study conducted during 1994-1995, SHV-2, SHV-2a and SHV-5 beta-lactamases were found among Klebsiella pneumoniae isolates in Dubrava University Hospital. High prevalence of ESBLs among K. pneumoniae strains in this hospital (20%) required further investigation. In this investigation, beta-lactamases from 42 K. pneumoniae strains collected in 1997 and 15 in 2004 from Dubrava University Hospital, were characterized in order to study the evolution of plasmid-encoded resistance to extended-spectrum cephalosporins and aztreonam in that hospital over a prolonged study period. Susceptibility to antibiotics was determined by disk-diffusion and broth microdilution method. beta-lactamases were characterized by isoelectric focusing, determination of hydrolysis of beta-lactam substrates, polymerase chain reaction and sequencing of bla(SHV) genes. All K. pneumoniae strains and their Escherichia coli transconjugants produced beta-lactamase with an isoelectric point of 8.2. Based on sequencing of bla(SHV) genes enzymes of all transconjugants were identified as SHV-5 beta-lactamase which conferred on the producing isolates high level of ceftazidime and aztreonam resistance. In this study, an outbreak of nosocomial infections caused by SHV-5 producing K. pneumoniae was described in 1997 which evolved to endemic spread of SHV-5 producing K. pneumoniae due to multiple plasmid transfer in the Dubrava University Hospital. The strains from 1997 and 2004 were not clonally related. Hospital hygiene measures should be applied in order to control the spread of epidemic strains through the hospital wards and the consumption of the broad-spectrum cephalosporins needs to be restricted to reduce the selection pressure which enables the proliferation of ESBL producers in hospital.
Collapse
Affiliation(s)
- B Bedenić
- Department of Microbiology, "A. Stampar" School of Public Health, Medical School, University of Zagreb, Zagreb, Croatia.
| | | | | | | | | | | | | | | |
Collapse
|
16
|
Monaco M, Williams I. Tetralogy of Fallot: fetal diagnosis to surgical correction. Minerva Pediatr 2012; 64:461-470. [PMID: 22992529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
Tetralogy of Fallot is one of the most common forms of cyanotic congenital heart disease. The diagnosis consists of four main anatomic features: a large ventricular septal defect (anterior malaligned), overriding aorta, right ventricular outflow obstruction and right ventricular hypertrophy. The refinement of fetal screening and echocardiography has led to an increase in prenatal diagnosis. Prenatal diagnosis along with the recognition of extracardiac anomalies and genetic abnormalities, including 22q11 deletion, sets the framework for prenatal counseling and can help predict the postnatal course and surgical repair. After birth, the degree of cyanosis and the presence of other extracardiac and cardiac abnormalities will direct the timing of surgical repair. Full surgical repair within the first year of life, either primary or after a palliative procedure, is the mainstay of therapy. Our understanding of the consequences of prior era surgeries and the detrimental effects of long standing pulmonary insufficiency has led to newer surgical and interventional techniques. Tetralogy of Fallot is a lifelong disease that requires careful follow up through adulthood with the potential for additional surgical and interventional procedures later in life.
Collapse
Affiliation(s)
- M Monaco
- Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY, USA
| | | |
Collapse
|
17
|
Palmieri B, Iannitti T, Capone S, Monaco M, Cecchini L. [First investigation on some aspects of Italian physicians: a statistical study]. Clin Ter 2012; 163:149-153. [PMID: 22555832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Physicians are often under increasing pressure and have a stressful lifestyle due to the high level of responsibility that characterizes their profession. Lack of free time and poor or even absent personal relationships may lead them to suffer from anxiety, depression, drug abuse and addiction, alcoholism and, in a worst case scenario, to suicide. The project "Medico-Cura-Te-Stesso" aims at taking care of the physicians' well-being, even if they are retired, who often underestimate the importance of their health status. Here we report the results of a survey, conducted on a sample of 251 physicians, concerning their illnesses, the drugs they use to cure themselves, prevention, overweight and its association with physical activity and diet, their artistic recreational activities and management of their free time.
Collapse
Affiliation(s)
- B Palmieri
- Department of Surgery and Surgical Specialties, University of Modena and Reggio Emilia Medical School, Surgical Clinic, Modena, Italy
| | | | | | | | | |
Collapse
|
18
|
Monaco F, Mondello B, Barone M, Familiari D, Sibilio M, La Rocca A, Lentini S, Monaco M. [Lung cancer with bronchial stenosis due to foreign body and Entoameba gingivalis infection]. G Chir 2011; 32:139-141. [PMID: 21453594] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Oral cavity infection by protozoarian agents may lead to pathologies such as stomatitis and gengivitis. An higher incidence has been reported in immunocompromised patients and in patients with dental disorders. Entoameba gingivalis localizes into oral cavity and in particular into interstitial and interdental spaces. Infection propagation to bronchial or lung parenchyma represents a complication. In this report the Authors, starting from a recently treated case, discuss on the incidence, complications and surgical management of lung infection by Entoameba gingivalis.
Collapse
Affiliation(s)
- F Monaco
- Policlinico Universitario G Martino, Messina
| | | | | | | | | | | | | | | |
Collapse
|
19
|
|
20
|
Mondello B, Barone M, Ruggeri P, Barresi P, La Rocca A, Sibilio M, Familiari D, Micali V, Vasta I, Nunnari F, Monaco M. [Bilateral and multiple traumatic pulmonary pseudo-cysts: a case report]. G Chir 2010; 31:220-224. [PMID: 20615363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
Traumatic pulmonary pseudocyst is a very rare consequence of blunt chest trauma characterized by formation of cystic like parenchymal lesions. Generally multiple and bilateral distribution is more rare than a single localization. The computed tomography (CT) scan has an higher diagnostic value compared with conventional chest X-ray. Prognosis of traumatic pseudocysts is generally good with benign clinical course and spontaneous resolution within several months. However initial strictly patient follow-up is necessary to early discover and treat potentially severe complications. Utility of chest magnetic resonance imaging (MRI) to exclude potentially severe infectious complications is described. Any complications required percutaneous drainage or surgical resection.
Collapse
Affiliation(s)
- B Mondello
- Università degli Studi di Messina, Azienda Ospedaliera Universitaria G. Martino
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Monaco M, Sanchini A, Grundmann H, Pantosti A. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J Clin Microbiol Infect Dis 2010; 29:771-7. [PMID: 20401508 DOI: 10.1007/s10096-010-0922-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2009] [Accepted: 01/21/2010] [Indexed: 11/25/2022]
Abstract
The aim of this study was to characterise invasive methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) strains from Italy and to investigate the presence of heteroresistant vancomycin-intermediate S. aureus (h-VISA). Eighty-two MSSA and 66 MRSA strains obtained from 19 laboratories were submitted to in vitro susceptibility testing; MRSA strains were also analysed by the macro Etest (MET) and vancomycin population analysis profiles (PAP) to detect the presence of h-VISA. Genotyping included the detection of agr locus, SCCmec typing, spa typing and multilocus sequence typing (MLST). By Etest, 66% of all isolates showed a minimum inhibitory concentration (MIC) >or=1.5 microg/ml and two MRSA strains were categorised as VISA (MIC = 3 microg/ml). Twelve MRSA strains were positive by MET; of these, 9 (14% of all MRSA) were confirmed as h-VISA by PAP. MRSA strains were assigned to 14 spa types, with t001, t008 and t041 including 77% of the isolates. The most common spa type, t041, characterised as ST228/273-MRSA-I (CC5) and comprising 24 isolates, included one VISA and eight h-VISA. This is the first description of a close association between h-VISA and t041, a spa type common in Italy and in other European countries, that highlights the importance of molecular typing to identify clones of special clinical relevance.
Collapse
Affiliation(s)
- M Monaco
- Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | | | | | | |
Collapse
|
22
|
Mondello B, Barone M, Barresi P, Familiari D, Micali V, Nunnari F, Monici D, Monaco M. [Etiology, pathophysiology and management of post-traumatic pneumomediastinum: our experience]. G Chir 2009; 30:365-368. [PMID: 19735617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
The Authors reported the cases of posttraumatic pneumomediastinum came to their observation over the past 8 years. The etiology, pathophysiology, diagnosis, treatment and blunt injures eventually associated are discussed. Conclude that in the absence of associated injuries the treatment and the course of post-traumatic pneumomediastinum are the same that spontaneous pneumomediastinum.
Collapse
Affiliation(s)
- B Mondello
- Universitá degli Studi di Messina, Azienda Ospedaliera Universitaria G. Martino, Dipartimento di Scienze Cardiovascolari e Toraciche
| | | | | | | | | | | | | | | |
Collapse
|
23
|
Perrone O, Mondello B, Barresi P, Barone M, Sibilo M, Monaco F, La Verde M, Vasta I, Monaco M. [Pneumotorax and cannabis]. MINERVA CHIR 2009; 64:313-316. [PMID: 19536058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
AIM After having read the articles by Treasure and Beshay about the particular incidence of spontaneous pneumothorax (SP) in patients with daily consumption of Cannabis the authors took a strictly control of these subjects reviewing their personal experience in the treatment of this condition. In particular, the prevalence of SP has been evaluated through genomic assay of monocorial twins. The strong impact of the inflammatory phenomena that have always supported the emphysema burning is 10 time higher among worldwide population and patients with SP. METHODS In order to determine the real incidence of spontaneous pneumothorax in patients with proved daily assumption of Cannabis a retrospective analysis of patients with history of Cannabis drug abuse has been performed. In the period from January 2002 and June 2007,12 consecutive patients with SP and history of Cannabis abuse were enrolled. Selection criteria were: 1) age <16 years; 2) single-sided spontaneous pneumothorax; 3) history of daily Cannabis assumption. Patients with previous thoracic surgery/trauma and positive anamnesis for other drug assumption (ODA), snorkelling or work exposition to pollutions were excluded. In order to avoid the clinical overlapping of pathology and clinical symptoms due to other factors, patients with pleural effusion and documented similar episodes were excluded. This series focused on particular on twins. In all the patients an endopleuric drainage tube was inserted, and 3 patients underwent toracostomy. RESULTS No operatory mortality and/or complications were observed. CONCLUSIONS The role of the thoracic surgeon is important to sensitize on the problem of the circulation of light drugs among young people and their effects on the lung activity.
Collapse
Affiliation(s)
- O Perrone
- Unità Operativa Complessa di Chirugia Toracica, Università di Messina, Messina, Italia
| | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Tangredi G, Monaco M, Perfetti B, Perego S. [Experience in risk assessment in variety type of work: reflection on reliability and judgement in method reference to European accord, 2004]. G Ital Med Lav Ergon 2009; 31:230-232. [PMID: 19827293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Interest in problems of work-related stress has been limited, till now, to its effects on health of workers. The aim of our study, lacking valid literature's instruments, is to experiment and to evaluate a risk's evaluation model to identify and prevent or manage problems of work-related stress also according to indications published in "European Framework Agreement on work-related stress" (08/10/2004). Our evaluation model (even according to art. 28 D.Lgs. 81/2008) has been experimented in a sample composed by 1470 employers in 19 Lomabardia's factories. Valued risk's results have been introduced in the risk assessment and they have been used to sanitary surveillance indications.
Collapse
Affiliation(s)
- G Tangredi
- Unità Operativa di Medicina del Lavoro, A.O. "G. Salvini" Garbagnate Milanese, Italy
| | | | | | | |
Collapse
|
25
|
Monaco F, Lentini S, Tancredi F, Savasta M, Perrone O, Monaco M, Gaeta R, Mondello B, Barone M. Chronic transverse sternal fracture. Role of CT scan and repair by an alternative use of the Synthes-Titanium Sternal Fixation System. G Chir 2009; 30:165-167. [PMID: 19419619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Chest wall fractures, including injuries of the sternum, usually heal spontaneously without specific treatment. However sometimes, they need surgical treatment. To treat these patients the selection criteria often are subjective in spite of many surgical devices for sternal osteosynthesis are available nowadays. One of the most recent device is the Synthes-Titanium Sternal Fixing System, usually used to treat post-sternotomy dehiscence. We describe the case of a 67-year-old man with previous history of chest trauma presenting to our institution with chronic transverse sternal fracture. We describe the pre-operative study, stressing the particular role of the CT scan and a surgical approach by an alternative use of the Synthes.
Collapse
Affiliation(s)
- F Monaco
- Università degli Studi di Messina, Policlinico G. Martino, Messina, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Orsi G, Mastroianni C, Giordano A, Monaco M, Venditti M. Lack of community-associated MRSA in Rome. J Hosp Infect 2009; 71:374-6. [DOI: 10.1016/j.jhin.2008.11.027] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2008] [Accepted: 11/11/2008] [Indexed: 11/26/2022]
|
27
|
Monaco M, Mondello B, Monaco F, Vasta I, Perrone O, Micali V, Barone M. Misunderstood cardiac involvement with heart impairment in traumatic sternal fracture: an enzyme-guided evaluation. G Chir 2009; 30:117-120. [PMID: 19351464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
BACKGROUND Isolated sternal fractures occur more and more frequently in traffic road accidents in particular after the introduction of the seat-belt law. This study sets out to assess by laboratory parameters the incidence and consequences of pericardial and myocardial involvement in sternal injury. PATIENTS AND METHODS Between June 1997 and March 2007, 50 consecutive patients were admitted to our Thoracic Surgical Unit with acute traumatic sternal fractures. X-ray, CT scan, standard 12-lead electrocardiogram (ECG) and echocardiographic evaluation were obtained in all patients. (28 males, 22 females), with displaced and undisplaced fractures. The patients were hospitalised for cardiorespiratory monitoring, pain control and physiotherapy. Oxygen implementation was performed to obtain an arterial saturation above 96%. Supplementary investigations or therapeutic interventions were assessed if clinically indicated. RESULTS Our data, according to literature, show that sternal trauma must be careful evaluated by monitoring of vital parameters. In our collection we have no mortality with complex comorbidity. The interparametric relation between laboratory values and cardiac involvement was not significant anyway . The prolonged CK-MB peak level in a large number of patients is related with cardiac impairment. CONCLUSIONS Our results suggest that in traumatic sternal fractures enzymatic activity of CK-MB, echocardiographic investigation and careful monitoring for the first 96 hours are necessary. The cardiac compliance is inadequate in polytrauma patients and can lead to cardiac impairment.
Collapse
Affiliation(s)
- M Monaco
- Università degli Studi di Messina, A.O.U. Policlinico "G. Martino", Cattedra e U.O.C. di Chirurgia Toracica, Italy
| | | | | | | | | | | | | |
Collapse
|
28
|
De Luca G, Griffo S, Monaco M, Fraioli G, Di Tommaso L, Stassano P. Combined endoscopic approach in the treatment of benign broncho-oesophageal fistula. Thorax 2008; 63:1024-5. [PMID: 18984818 DOI: 10.1136/thx.2007.091686] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
The treatment of benign broncho-oesophageal fistula is usually surgical but sometimes other methods of treatment are preferred. The case history is described of an adult in poor general condition in which an endoscopic approach combined with the use of fibrin glue on the bronchial side and metallic clips on the oesophageal side was used to close the fistula.
Collapse
Affiliation(s)
- G De Luca
- Cardiothoracic Surgery Unit, Istituto Clinico Pineta Grande, Castel Volturno (CE), Naples, Italy.
| | | | | | | | | | | |
Collapse
|
29
|
Monaco M, Mondello B, Barone M, Barresi P, La Rocca A, Sibilio M, Familiari D, Monaco F, Nunnari F, Monici D, Puliafito M, Micali V. [Thoracic trauma: incidence, social and economic costs, educational opportunities. Experience on the last eight years of Thoracic Surgical Unit of Messina University]. G Chir 2008; 29:488-492. [PMID: 19068186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
The Authors, after extensive introduction on the incidence, etiology, classification, pathophysiology, possible complications, diagnosis and treatment of thoracic trauma, relate their experience on the last eight years, stressing the diagnostic and therapeutic strategy in management of trauma simple and complicated and assessing finally serious social impact of these pathologies and the educational opportunities provided.
Collapse
Affiliation(s)
- M Monaco
- Università degli Studi di Messina, Azienda Ospedaliera Universitaria G Martino, Dipartimento di Scienze CArdiovascolari e Toraciche, Cattedra ed UOC de Chirurgia Toracica
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Monaco M, Mondello B, Spinelli F, Gaeta R, Carella G, Lentini S, Monaco F. Endovascular repair of aortic lesions associated to video-assisted thoracoscopy surgery after chest trauma. MINERVA CHIR 2008; 63:329-334. [PMID: 18923343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
AIM Trauma of the thoracic aorta for blunt trauma shows a very high incidence of mortality. Hospital mortality rate after aortic open surgery is between 15% and 30%. Endovascular management represents an alternative treatment Associated lesions are usually seen in those critical patients. Hemothorax may be present. The authors propose a combined treatment of endovascular repair for the aortic lesion and video-assisted thoracoscopy surgery (VATS) for the treatment of chest bleeding complications. METHODS The authors report a series of three patients with post-traumatic aortic lesion and hemothorax. In two patients endovascular procedure was first performed, followed by VATS, few days later, for retained hemothorax. In the third patient the two procedures were performed at the same time because of the patient's critical conditions. RESULTS There was technical success of stent-graft placement in all the treated cases. No postoperative mortality. No postoperative paraplegia. No VATS converted to thoracotomy. The postoperative follow-up time range between 10 and 19 months. CONCLUSION Considering the relatively short procedural time and minimally invasive approach of both techniques, the concomitant use of them may represent an alternative to standard open surgery in cases of thoracic aorta lesions associated with hemothorax. Those procedures may be performed sequentially or together in emergency cases with intra-thoracic more active bleeding to exclude or to treat intra thoracic bleeding.
Collapse
Affiliation(s)
- M Monaco
- Department of Thoracic and Cardio-Vascular Surgery, Policlinic Hospital, University of Messina, Messina, Italy
| | | | | | | | | | | | | |
Collapse
|
31
|
Alexander D, Clarkson J, Buchanan R, Chadwick G, Chesters R, Drisko CL, Douglass CW, Farrell L, Fletcher K, Makoni F, Monaco M, Nordquist B, Park NI, Riggs S, Schou L, Smales FC, Stamm JW, Toh CG, Volpe T, Ward P, Warren P. Exploring opportunities for collaboration between the corporate sector and the dental education community. Eur J Dent Educ 2008; 12 Suppl 1:64-73. [PMID: 18289269 DOI: 10.1111/j.1600-0579.2007.00481.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
The ultimate purpose of both dental industry and dental education is to improve the oral health of the public. This report provides background information on the different roles and objectives of the dental industry and dental education communities, the different operating environment of each sector and also areas of common interest where collaboration will be of mutual benefit. The report addresses five areas for potential collaboration between the dental industry and the dental education communities: 1. Contribution to joint activities. 2. Effectiveness and efficiency. 3. Workforce needs. 4. Middle- and low-income countries. 5. The future of International Federation of Dental Educators and Associations (IFDEA). The traditional areas of support and their limitations that have been provided by industry are outlined in the report and some new approaches for collaboration are considered. Industry-based research has been an important factor in developing new products and technologies and in promoting oral health. However there is a need to facilitate the introduction of these developments at an early stage in the education process. Industry has to operate in an efficient manner to remain competitive and maximise its returns and therefore survive. The academic sector operates in a different environment and under different governance structures; although some trends are noted towards adoption of greater efficiency and financial accountability similar to industry. Opportunities to jointly develop best business practices should be explored. Industry has responded well to the oral health needs of the public through the development of new products and technologies. The education community needs to respond in a similar way by examining different healthcare delivery models worldwide and developing programmes to train members of the dental team to cater for future needs and demands of communities in different regions of the world. The reputation of industry-based scientists and clinicians is high, and their role in contributing to the dental education process in practical ways needs to be explored and further developed. Closer relationships between industry scientists and faculty and students could assist industrys need and desire to develop new technologies for the broader dental care system. The corporate sector can play a key role in the future success of IFDEA by providing support and expertise in developing areas such as regional leadership institutes, a Global Faculty and Network and in collaborating in developing continuing education programmes as well as involvement in its governance. Thirteen recommendations are made in the report. These are considered to be important initial steps in developing the already strong relationship between the education and corporate sectors. Partnership and collaborating more effectively along the lines suggested should, almost certainly, generate mutually beneficial outcomes, whilst serving over the long term to elevate the publics oral health status on a global basis.
Collapse
|
32
|
Feltrin C, Lima AS, Monaco M, Wilson SM, Kim D, Wheeler MB, Rodrigues JL. 29 EVALUATION OF DIFFERENT FUSION PARAMETERS IN THE RECONSTRUCTION OF SWINE HANDMADE CLONING EMBRYOS. Reprod Fertil Dev 2008. [DOI: 10.1071/rdv20n1ab29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
The goal of this experiment was to compare different fusion parameters in the handmade cloning technique to produce cloned swine embryos. After in vitro maturation of 618 oocytes, 431 (69.8%) presented a visible polar body and were used in the experiment. The next step was the removal of the cumulus oophorus cells and the digestion of the zona pellucida using pronase (5 mg mL–1) in HEPES TCM199. Oocytes were then exposed to a medium containing cytochalasin B (5 µg mL–1) for 15 min before being bisected with a hand-held blade. The bisected oocytes (cytoplasts) were then placed in medium supplemented with Hoechst 33342 and exposed to UV light to select cytoplasts without metaphase II plates. Next, two cytoplasts and a mesenchymal stem cell (nucleus donor) were pushed together in a phytohemagglutinin (550 µg mL–1) solution. Once adhered, these structures were divided into 3 groups (G) to be fused using different parameters: (G1) 2 pulses (DC) of 0.6 kV cm–1 for 30 µs, (G2) 2 pulses (DC) of 0.9 kV cm–1 for 30 µs, and (G3) 2 pulses (DC) of 1.2 kV cm–1 for 30 µs. For all three groups, 0.3 m of mannitol solution (without calcium) was used in the fusion chamber, and an initial pre-pulse (AC) of 10V for 15 s was performed to permit the alignment of 100% of the cytoplast-donor cell structures. After fusion, reconstructed embryos were activated in 0.3 m mannitol and 0.1 mm calcium in the fusion chamber using 2 pulses of 0.9 kV cm–1 for 30 µs followed by incubation in 10 µg mL–1 of cycloheximide solution for 4 h. Afterwards, the reconstructed embryos were transferred to NCSU23 medium supplemented with amino acids (nonessential and essential) and 0.4% bovine serum albumin. The embryos were cultured at 39�C in a 100% humidified atmosphere containing 5% CO2, 5% O2, and 90% N2. Cleavage rates were evaluated after 48 h of culture. For G1, the fusion rate was 43% (25/58) with 72% cleavage (18/25), the G2 fusion rate was 87% (56/64) with 80% cleavage (45/56), and the G3 fusion rate was 79% (53/67) with 69% cleavage (37/53). Statistical analysis was performed using the chi-square test. There were no significant differences in fusion rates between groups G2 and G3, but the fusion rate of these groups was significantly different from that of G1 (P < 0.05). No significant differences in cleavage rate were observed among the three groups. In conclusion, fusion using 2 pulses at either 0.9 or 1.2 kV cm–1 for 30 µs was more efficient for embryo reconstruction in the handmade cloning technique compared to that using 2 pulses at 0.6 kV cm–1 for 30 µs. Further studies need to be performed to improve cleavage rates and assess development to the blastocyst stage.
Collapse
|
33
|
Nicoletti G, Schito G, Fadda G, Boros S, Nicolosi D, Marchese A, Spanu T, Pantosti A, Monaco M, Rezza G, Cassone A, Garaci E. Bacterial Isolates from Severe Infections and Their Antibiotic Susceptibility Patterns in Italy: a Nationwide Study in the Hospital Setting. J Chemother 2007. [DOI: 10.1179/joc.2007.19.5.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
34
|
Pantosti A, Gherardi G, Monaco M, Camilli R, D’Ambrosio F, Del Grosso M, D’Ancona P, Manganelli R, Dicuonzo G. STREPTOCOCCUS PNEUMONIAE IN ITALIA: CLONI CIRCOLANTI DI CEPPI NON VACCINALI ANTIBIOTICO-RESISTENTI. Microbiol Med 2007. [DOI: 10.4081/mm.2007.2744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
35
|
Tinelli M, Pantosti A, Lusardi C, Vimercati M, Monaco M. First detected case of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infection in Italy. ACTA ACUST UNITED AC 2007; 12:E070412.1. [PMID: 17439803 DOI: 10.2807/esw.12.15.03173-en] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have been increasingly frequently isolated from patients in many areas of the United States, and have started to replace hospital-acquired MRSA (HA-MRSA) as a cause of healthcare-associated infections. This article, describes the first Italian case of CA-MRSA skin and soft tissue infection (SSTI).
Collapse
Affiliation(s)
- M Tinelli
- Division of Infectious and Tropical Diseases, Hospital of Lodi, Lodi, Italy.
| | | | | | | | | |
Collapse
|
36
|
Pavia R, Spinelli F, Monaco M, Mondello B, Monaco F, Gaeta R. Lung cancer and cardiovascular diseases: occurrence, comorbidity and surgical timing. J Cardiovasc Surg (Torino) 2007; 48:227-31. [PMID: 17410071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
AIM The authors discuss tumor histological type, TNM staging and time of first occurrence of lung cancer, as well as related cardiovascular diseases, underlining type of treatment, surgical timing, surgical mortality, post-surgical complications and potentially additional therapies. METHODS A total of 189 patients underwent surgery for non-small cell lung cancer (NSCLC) (Stage I-II), 35 (17.5%) of which presented with surgically relevant concurrent cardiovascular disease (8 coronary artery disease, 4 carotid stenosis, 8 obstructing artery disease, 15 aortic aneurysm). In most cases, surgical timing provides for cardiovascular disease treatment completion first, followed by lung resection only afterwards. Alternatively, concomitant cardiovascular and lung cancer treatment averts the need for repeated surgery, even though the intraoperative complications rate is higher, as long as patients are hemodynamically stabile. RESULTS No remarkable surgical mortality was observed; stay in hospital ranged from 8 to 18 days. A 5-year follow-up was carried out in only 95/189 patients; 11/18 (61%) with concurrent cardiovascular disease and 46/77 (59%) with lung cancer alone are still alive. CONCLUSIONS In 17% of cases, surgical treatment by the simultaneous and the differentiated approach for cancer and cardiovascular disease proved essential; comorbidity as an identifier of the strong correlation between the two diseases had a major impact on prognosis.
Collapse
Affiliation(s)
- R Pavia
- Unit of Thoracic Surgery, Department of Cardiovascular and Thoracic Sciences, G.Martino University Hospital, Messina, Italy.
| | | | | | | | | | | |
Collapse
|
37
|
Gherardi G, Monaco M, Camilli R, D'Ambrosio F, D'Ancona P, Manganelli R, Dicuonzo G, Pantosti A. P996 Pneumococcal invasive isolates of non-vaccine serotypes in Italy, 1999–2003 (pre-vaccine era). Int J Antimicrob Agents 2007. [DOI: 10.1016/s0924-8579(07)70837-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
38
|
Stassano P, Di Tommaso L, Vitale DF, Monaco M, Iannelli G, Mottola M, Musumeci A, Spampinato N. Aortic valve replacement and coronary artery surgery: determinants affecting early and long-term results. Thorac Cardiovasc Surg 2007; 54:521-7. [PMID: 17151966 DOI: 10.1055/s-2006-924467] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
BACKGROUND We studied factors influencing early and late results in patients operated on for aortic valve replacement and coronary artery bypass graft. METHODS 175 patients were retrospectively analysed over a 10-year period ending in December 2002. There were 135 males and 40 females with a mean age of 62.7 +/- 8.9 years; 109 were in NYHA class III/IV; 45 required an urgent operation, and 103 mechanical valves and 72 biological valves were implanted. RESULTS There were 11 operative deaths (6.3 %). Statistical analysis (logistic regression) showed that previous myocardial infarction, poor NYHA class, and low LVEF had a significant effect on early death. There were 52 late deaths at a mean follow-up of 82.7 +/- 38.8 months. Using a Cox survival analysis for any causes, age, urgent operation, low LVEF, and creatinine had a strong impact on unfavourable late outcome. CONCLUSIONS A combination of a patient-related factor (age), cardiac-related condition (low LVEF), co-morbid condition (renal dysfunction), and operative cause (urgent operation) is the most important predictor of late clinical outcome for this combined surgical procedure.
Collapse
Affiliation(s)
- P Stassano
- Cardiac Surgery, University Federico II, Naples, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Mondello B, Sibilio M, Pavone A, Monaco F, Nunnari F, Micali V, Vasta I, Perrone O, Monaco M. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers]. G Chir 2007; 28:7-12. [PMID: 17313726] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
BACKGROUND The purpose of this study is to assess, through the retrospective analysis of our experience and the literature review, whether the limited pulmonary resection is comparable to lobectomy for treatment of the peripheral stage IA (T1N0M0) non-small cell lung cancers (NSCLC), in terms of oncologic radicality, survival and rate of local, regional and systemic recurrences. Moreover it has been considered the impact of the limited resections in comparison with the lobar resections on the postoperative pulmonary function. PATIENTS AND METHODS We have analyzed a consecutive series of 36 patients, 28 men and 8 women, of inclusive age among the 61 to 81 years (average 73 years), who underwent surgical resection from January 2000 to December 2003 for T1N0M0 peripheral NSCLC; 11 limited resections and 25 lobectomies have been performed. Comparatively survival and recurrences (follow-up period of 3-5 years) are been analyzed, as well as the pulmonary function tests at 1 year after surgery. RESULTS The 3-year and 5-year survivals were 88% and 82% in the patient's group underwent to limited resection , 93% and 88% in the patient's group underwent to lobectomy. Postoperative local recurrence was noted in 1 patient (9%) of the first group and in 1 patient (4%) of the second group. One year after surgery was noted a moderate decline in the forced expiratory volume in 1 second (FEV1) and in the diffusing capacity for carbon monoxide (DLCO) in the patients who underwent to lobar resection, whereas in the patient's group submitted to limited resection was observed a substantial maintenance, except for the DLCO, of the preoperative pulmonary function tests. CONCLUSIONS Our limited experience, according to the actual tendencies of the literature, show that the limited pulmonary resections, in selected patients with peripheral stage IA NSCLC, represents a valid alternative to lobectomy in terms of survival and recurrence's rate, also determining a lower decrement of the postoperative pulmonary function. Therefore the segmentectomy can be considered, in such cases, the gold-standard procedure even if the patient is able to bear a wider resection.
Collapse
Affiliation(s)
- B Mondello
- Università degli Studi di Messina, Azienda Ospedaliera Universitaria G. Martino, Dipartimento di Scienze Cardiovascolari e Torachiche, Cattedra e U.O.C. di Chirurgia Toracica, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Di Tommaso L, Monaco M, Piscione F, Sarno G, Iannelli G. Endovascular Stent Grafts as a Safe Secondary Option for Paraanastomotic Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg 2007; 33:91-3. [PMID: 16798027 DOI: 10.1016/j.ejvs.2006.05.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2005] [Accepted: 05/08/2006] [Indexed: 11/30/2022]
Abstract
OBJECTIVE To describe our experience of endovascular repair of para-anastomotic aortic aneurysm. METHODS AND RESULTS From March 2001 to December 2004 we identified 6 patients with a para-anastomotic aortic aneurysms following previous open repair of abdominal aortic aneurysm. All patients were treated with endovascular surgery under epidural anaesthesia. There were no major complications, surgical conversions or deaths. Four patients received a bifurcated aortic stent-graft, and two an aorto-uniliac stent-graft followed by a femoro-femoral bypass. At follow-up (mean 26.1+/-10.2 months) there were no deaths, endoleaks or graft migrations observed. CONCLUSION Endovascular surgery, avoiding general anesthesia and re-laparotomy, is the ideal technique for treatment of this complication resulting from failed primary conventional AAA repair.
Collapse
Affiliation(s)
- L Di Tommaso
- Department of Cardiac Surgery, University Federico II of Naples, Italy.
| | | | | | | | | |
Collapse
|
41
|
Tommaso LD, Monaco M, Piscione F, Sarno G, Iannelli G. Letter to editor re: endovascular repair of para-anastomotic aortic aueurysms. Eur J Vasc Endovasc Surg 2006; 33:256; author reply 256-7. [PMID: 17137803 DOI: 10.1016/j.ejvs.2006.10.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2006] [Accepted: 10/25/2006] [Indexed: 10/23/2022]
|
42
|
Monaco M, Mondello B, Monici D, Nunnari F, Pavone A, Puliafito M, Surleti S, Monaco F, Micali V, Familiari D. [Indications, surgical strategies and evaluation of prognostic factors in the treatment of pulmonary metastases]. G Chir 2006; 27:442-7. [PMID: 17198555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
Abstract
Pulmonary metastases resection is a method universally accepted in selected patients. Long-term survival reaches good levels after complete resection of lung metastases independently of primary tumour histology. The Authors emphasizes literature data; they report data of their experience no statistically significant but useful for valuation of results. They discuss of advantages vs disadvantages of the surgical procedures. In conclusion they believe metastasectomy is a safe treatment of pulmonary metastases.
Collapse
Affiliation(s)
- M Monaco
- Università degli Studi di Messina, Cattedra di Chirurgia Toracica
| | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Longo B, Pantosti A, Luzzi I, Placanica P, Gallo S, Tarasi A, Di Sora F, Monaco M, Dionisi AM, Volpe I, Montella F, Cassone A, Rezza G. An outbreak of Acinetobacter baumannii in an intensive care unit: epidemiological and molecular findings. J Hosp Infect 2006; 64:303-5. [PMID: 16978736 DOI: 10.1016/j.jhin.2006.07.010] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2006] [Accepted: 07/21/2006] [Indexed: 11/18/2022]
|
44
|
D’Ancona F, Alfonsi V, Giannitelli S, Ciofi degli Atti M, Monaco M, D’Ambrosio F, Del Grosso M, Pantosti A, AR-ISS G. TREND DI ANTIBIOTICO RESISTENZA NELLE INFEZIONI INVASIVE: I RISULTATI DELLA SORVEGLIENZA AR-ISS. Microbiol Med 2006. [DOI: 10.4081/mm.2006.3134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
|
45
|
Silvestre C, Cimmino S, Di Pace E, Di LOrenzo ML, Monaco M. Morphology, phase structure, and properties of polyolefin/hydrogenated oligocyclopentadiene blends. J MACROMOL SCI B 2006. [DOI: 10.1080/00222349608220389] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- C. Silvestre
- a Istituto di Ricerca e Tecnologia delle , Materie Plastiche , CNR-ViaToiano, 6, 80072, Arco Felice, NA, Italy
| | - S. Cimmino
- a Istituto di Ricerca e Tecnologia delle , Materie Plastiche , CNR-ViaToiano, 6, 80072, Arco Felice, NA, Italy
| | - E Di Pace
- a Istituto di Ricerca e Tecnologia delle , Materie Plastiche , CNR-ViaToiano, 6, 80072, Arco Felice, NA, Italy
| | - M. L. Di LOrenzo
- a Istituto di Ricerca e Tecnologia delle , Materie Plastiche , CNR-ViaToiano, 6, 80072, Arco Felice, NA, Italy
| | - M. Monaco
- a Istituto di Ricerca e Tecnologia delle , Materie Plastiche , CNR-ViaToiano, 6, 80072, Arco Felice, NA, Italy
| |
Collapse
|
46
|
Monaco M, Scisca C, Pavia R, Sibilio M, La Rocca A, Familiari D, Pavone A, Surleti S, Monaco F, Mondello B. [Percutaneous radio frequency thermal ablation of non-resectable lung cancer: state of the art]. G Chir 2006; 27:113-8. [PMID: 16681873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/09/2023]
Abstract
BACKGROUND Unfortunately, as of yet, most lung cancers are not operable as soon as diagnosis is available; in these situations chemo- and radio-therapy still play a key role, albeit palliative, improving survival rate moderately, but are not lacking in toxic effects, especially in case of concurrent pathology, reduced cardio-respiratory functionality or being advanced in years. Therefore thermal ablation mini-invasive techniques, already employed as ancillary treatments of hepatic cancer or in place of surgery, have been performed for these pathologies. AIM Aim of this work is to define the current state of the art for Radio-Frequency Ablation (RFA) to be performed on non-resectable lung cancer, also by means of a thorough review of international literature, from which to infer purposes, suggestions, methodologies, effectiveness, safety, complications and achievements, also in terms of the possible improvement of life quality and/or survival expectancy. PATIENTS AND METHODS Patients have been carefully selected. Pulmonary nodules have been treated with TC or echo-guided percutaneous thermal ablation and, afterwards, evaluated by radiological and clinical (sometimes histopathological) follow-up. RESULTS The size of the RFA-treated nodules is necessary in order to evaluate full or partial necrosis extent and, therefore, average survival rate. CONCLUSIONS Availability of more extensive and homogeneous case histories, as well as standard follow-up (TC and/or histopathological sampling) methodologies, is required. Nevertheless several authors agree that RFA is a safe and effective technique within the framework of a substitutive or complementary treatment of non-operable lung cancer. The best results can be achieved for cancers less than 3 cm wide; RFA, performed before chemo- and/or radio-therapy, plays a neoadjuvant role for larger cancers, decreasing cancer volume and weakening the symptoms.
Collapse
Affiliation(s)
- M Monaco
- Università degli Studi di Messina, Azienda Ospedaliera Universitaria G. Martino, Dipartimento di Scienze Cardiovascolari e Toraciche
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Iannelli G, Monaco M, Di Tommaso L, Piscione F, Stassano P, Mainenti PP, Laurino S, Spampinato N. Endovascular vs. Open Surgery of Abdominal Aortic Aneurysm in High-Risk Patients: A Single Center Experience. Thorac Cardiovasc Surg 2005; 53:291-4. [PMID: 16208615 DOI: 10.1055/s-2005-837680] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND We compared two groups of high-risk patients with abdominal aortic aneurysm to assess the safety and efficacy of endovascular repair vs. open surgery. METHODS From January 1998 to July 2003, sixty-two high-risk patients were divided into two groups: group A consisted of 28 (46 %) open surgery patients and group B consisted of 34 (54 %) patients who underwent endovascular repair. RESULTS Four patients (14.3 %) in the open surgery group died, while no deaths occurred in the endovascular group ( p < 0.05). There were 14 complications in 8 patients of the open surgery group versus 2 complications in 2 patients of the endovascular group ( p = 0.01). At follow-up there were 4 (16.6 %) deaths in group A and 3 (8.8 %) in the endovascular group ( p = n. s.). CONCLUSIONS While the use of endovascular repair in patients who are physiologically fit for open surgical repair remains controversial, we believe that patients with multiple or advanced comorbidities, i.e. high-risk patients, can benefit from the endografting procedure.
Collapse
Affiliation(s)
- G Iannelli
- Department of Cardiac Surgery, University of Naples Federico II, Naples, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
48
|
Monaco M, D’Ambrosio F, Del Grosso M, Giannitelli S, Ciofi degli Atti M, Pantosti A, D’Ancona F, AR-ISS G. ANTIBIOTICO-RESISTENZA IN ITALIA: RISULTATI DEL PROGETTO AR-ISS NEL PERIODO 2003-2004. Microbiol Med 2005. [DOI: 10.4081/mm.2005.3516] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
49
|
Monaco M, Di Tommaso L, Mottola M, Stassano P, Iannelli G. Clinical outcome for on-pump myocardial revascularization in patients with mild renal dysfunction. Thorac Cardiovasc Surg 2005; 53:46-51. [PMID: 15692919 DOI: 10.1055/s-2004-830457] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
BACKGROUND Coronary artery disease is the major cause of death in patients with chronic renal failure. We studied the early and long-term outcome of patients with mild chronic renal impairment, preoperative regular diuresis, and normal potassium levels having undergone pump myocardial revascularization. METHODS From January 1992 to December 2000, 67 patients with serum creatinine level higher than 1.7 mg/dl and less than 2.5 mg/dl underwent on-pump myocardial revascularization. The patients were divided into 2 groups and treated with renal doses of dopamine in the postoperative or preoperative period, respectively. A homogeneous group of 100 patients was selected as control. RESULTS There were no statistically significant differences in mortality and morbidity between the two groups A, while there was a significant difference in cardiac and respiratory complications, ICU stay and LOS between the A and B group in the early and long-term follow-up. Survival at 12-year follow-up is significantly higher in the B group. CONCLUSIONS Patients with relatively mild renal insufficiency should be evaluated carefully for open cardiac surgery due to the significant increase in early and long-term morbidity and mortality.
Collapse
Affiliation(s)
- M Monaco
- Department of Cardiac Surgery, University "Federico II", Naples, Italy.
| | | | | | | | | |
Collapse
|
50
|
Martmelli R, Tobia L, Lupi A, Monaco M, Capitano T, Ponzi I, Paoletti A. [Longitudinal study of a population exposed to risk of biomechanical overload of the upper limb]. G Ital Med Lav Ergon 2005; 27:237-9. [PMID: 16124537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
One of the most important factors of the work-related musculoskeletal disorders of the upper extremities (WMSDs) is the biomechanical overload. The purpose of this study is to evaluate the possibility of the worker fitting to the job, to decrease the upper limb repetitive stress. In order to this aim, we have collected and compared, in different controls at the distance of two years, the clinical-anamnestic and instrumental data of a cohort of workers in a car industry.
Collapse
Affiliation(s)
- R Martmelli
- Cattedra e Scuola di Specializzazione in Medicina del Lavoro, Dipartimento MISP, Università degli Studi, L'Aquila, Italy
| | | | | | | | | | | | | |
Collapse
|